NuVasive Gains Additional FDA Clearance for CoRoent Small Interlock

NuVasive received FDA 510(k) clearance for expanded indications for the CoRoent Small Interlock™ system, allowing for on-label use of the device at multiple contiguous levels from C2 to T1 for anterior cervical discectomy and fusion. This is an alternative to other systems on the market cleared for only one- or two-level use.

CoRoent Small...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us